Literature DB >> 20718076

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder.

Louis S Matza1, Robert Morlock, Chris Sexton, Karen Malley, Douglas Feltner.   

Abstract

The aim of the current study was to identify and evaluate cutoffs for mild, moderate, and severe ranges of Hamilton Anxiety Rating Scale (HAM-A) scores. Data were from a four-week randomized trial of treatment for generalized anxiety disorder. Measures included the HAM-A, SF-36, Hospital Anxiety and Depression Scale (HADS), and Clinical Global Impressions of Severity (CGI-S) scale. HAM-A cutoffs were identified based on literature review, expert panel input, and MANOVA models. The optimal cutoff set was evaluated based on association with clinician CGI-S ratings. The sample included 144 patients (56.3% female; 73.6% white; mean age = 35.7 years; mean baseline HAM-A score = 23.7). The optimal HAM-A score ranges were: mild anxiety = 8-14; moderate = 15-23; severe ≥ 24 (scores ≤ 7 were considered to represent no/minimal anxiety). Analysis of variance (ANOVA) models found statistically significant differences among these groups in the SF-36 and HADS. The HAM-A severity ranges closely corresponded to clinicians' CGI-S ratings. The study represents the first step towards developing severity ranges for the HAM-A. These cutoffs should be used with caution and validated in larger samples. If the proposed cutoffs are accepted for general use, they could make results more meaningful and interpretable for researchers, clinicians, and patients.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20718076      PMCID: PMC6878292          DOI: 10.1002/mpr.323

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  41 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A).

Authors:  M K Shear; J Vander Bilt; P Rucci; J Endicott; B Lydiard; M W Otto; M H Pollack; L Chandler; J Williams; A Ali; D M Frank
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

3.  The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.

Authors:  W Maier; R Buller; M Philipp; I Heuser
Journal:  J Affect Disord       Date:  1988 Jan-Feb       Impact factor: 4.839

4.  The assessment of changes in anxiety in a drug trial: a comparison of methods.

Authors:  R Kellner; A V Kelly; B F Sheffield
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  Estimation of symptom-free days in generalized anxiety disorder.

Authors:  George J Wan; Huabin F Zhang; Michael A Tedeschi; David Hackett
Journal:  Curr Med Res Opin       Date:  2006-03       Impact factor: 2.580

6.  Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients.

Authors:  Ivo Aben; Frans Verhey; Richel Lousberg; Jan Lodder; Adriaan Honig
Journal:  Psychosomatics       Date:  2002 Sep-Oct       Impact factor: 2.386

7.  Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; M Katherine Shear; Mary Amanda Dew; Mark D Miller; Bruce G Pollock; Patricia Houck; Barbara Tracey; Charles F Reynolds
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

8.  A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

Authors:  Alan J Lenox-Smith; Alan Reynolds
Journal:  Br J Gen Pract       Date:  2003-10       Impact factor: 5.386

9.  Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis.

Authors:  Diane C Zelman; Deborah L Hoffman; Raafat Seifeldin; Ellen M Dukes
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

10.  Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

Authors:  Stuart A Montgomery; David V Sheehan; Paolo Meoni; Vincent Haudiquet; David Hackett
Journal:  J Psychiatr Res       Date:  2002 Jul-Aug       Impact factor: 4.791

View more
  49 in total

1.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

2.  The use of research measures in adult clinical practice.

Authors:  Joan Busner; Stuart L Kaplan; Nicholas Greco; David V Sheehan
Journal:  Innov Clin Neurosci       Date:  2011-04

3.  Incidence and psychological-behavioral characteristics of refractory functional dyspepsia: a large, multi-center, prospective investigation from China.

Authors:  Shu-Man Jiang; Lin Jia; Xiao-Gai Lei; Ming Xu; Sheng-Bing Wang; Jing Liu; Min Song; Wei-Dong Li
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

4.  Preventing maternal mental health disorders in the context of poverty: pilot efficacy of a dyadic intervention.

Authors:  Pamela Scorza; Catherine Monk; Seonjoo Lee; Tianshu Feng; Obianuju O Berry; Elizabeth Werner
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-01

5.  Psychometric Properties of the Reconstructed Hamilton Depression and Anxiety Scales.

Authors:  Eliora Porter; Dianne L Chambless; Kevin S McCarthy; Robert J DeRubeis; Brian A Sharpless; Marna S Barrett; Barbara Milrod; Steven D Hollon; Jacques P Barber
Journal:  J Nerv Ment Dis       Date:  2017-08       Impact factor: 2.254

6.  Effect of Hatha Yoga on Anxiety: A Meta-Analysis.

Authors:  Stefan G Hofmann; Giovanbattista Andreoli; Joseph K Carpenter; Joshua Curtiss
Journal:  J Evid Based Med       Date:  2016-05-20

7.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Effect of amitriptyline on gastrointestinal function and brain-gut peptides: a double-blind trial.

Authors:  Wei Huang; Shu-Man Jiang; Lin Jia; Le-Qing You; Yao-Xing Huang; Yan-Mei Gong; Gui-Qin Wang
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

9.  Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.

Authors:  Elena Olariu; José-Ignacio Castro-Rodriguez; Pilar Álvarez; Carolina Garnier; Marta Reinoso; Luis Miguel Martín-López; Jordi Alonso; Carlos G Forero
Journal:  Qual Life Res       Date:  2014-10-04       Impact factor: 4.147

10.  Comparative effectiveness of medication versus cognitive-behavioral therapy in a randomized controlled trial of low-income young minority women with depression.

Authors:  Juned Siddique; Joyce Y Chung; C Hendricks Brown; Jeanne Miranda
Journal:  J Consult Clin Psychol       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.